Authors:Evan C. Chen, Dana-Farber Cancer InstituteHelen Gandler, University of VermontIsidora Tošić, Dana-Farber Cancer InstituteGeoffrey G. Fell, Dana-Farber Cancer InstituteAshlee Fiore, CRISPR TherapeuticsOlga Pozdnyakova, Brigham and Women’s HospitalDaniel J. DeAngelo, Dana-Farber Cancer InstituteIlene Galinsky, Dana-Farber Cancer InstituteMarlise R. Luskin, Dana-Farber Cancer InstituteMartha S. Wadleigh, Dana-Farber Cancer InstituteEric S. Winer, Dana-Farber Cancer InstituteRebecca Leonard, Dana-Farber Cancer InstituteKelsey O'Day, Bluebird BioAdrienne de Jonge, Karyopharm TherapeuticsDonna Neuberg, Dana-Farber Cancer InstituteA. Thomas Look, Dana-Farber Cancer InstituteRichard M. Stone, Dana-Farber Cancer InstituteDavid Alan Frank, Emory UniversityJacqueline S. Garcia, Dana-Farber Cancer Institute
Date:2023
Publisher:American Association for Cancer Research
Authors:M Abramovitz, VM Institute of ResearchBG Barwick, Emory UniversityS Willis, Scripps Research Institute FloridaB Young, Scripps Research Institute FloridaC Catzavelos, McGill UniversityZ Li, VM Institute of ResearchM Kodani, Emory UniversityW Tang, Emory UniversityM Bouzyk, Emory UniversityCarlos S Moreno, Emory UniversityB Leyland-Jones, Emory University